Clinical Trial Update: An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing OROS methylphenidate HCl, Ritalin, and placebo in children with ADHD has completed, assessing effectiveness and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• OROS Methylphenidate HCl (methylphenidate hydrochloride (extended-release))
• Ritalin (methylphenidate)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED